510(k) Report

510(k) · Cleared

Cleared

Ultrafuse

K130531510(k) TraditionalCleared Apr 8, 2014403-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Baxter Healthcare Corp · MQV Filler, Bone Void, Calcium Compound

Cleared on Apr 8, 2014 as substantially equivalent to K071206 (Apatech, Ltd., 2007) and 2 other predicates after a 403-day review. Its family tree reaches back 5 generations to 1996. 7 later devices descend from it.

Decided
Apr 8, 2014
Review
403 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
3

Its longest line of descent runs back 5 generations to K960978 (1996). 10 ancestors in all. 7 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2008: 2 other ancestors2002: 1 other ancestor2000: 1 other ancestor1997: 1 other ancestor2018: 1 descendant cleared2020: 3 descendants cleared2019: 1 descendant cleared2024: 2 descendants clearedK960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 1996K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K030131 · Ossatura BCP Bone Void Filler · Isotis NV · 2003K040082 · Pore-SI Bone Graft Substitute · Apatech, Ltd. · 2004K071206 · Actifuse Abx E-Z-Fil Putty Bone Graft Substitute · Apatech, Ltd. · 2007 · recalled1995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors3 generations back: 1 other ancestor4 generations back: 1 other ancestor5 generations back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 2 descendants3 generations forward: 4 descendants K071206 · Actifuse Abx E-Z-Fil Putty Bone Graft Substitute · Apatech, Ltd. · 2007 · recalledK040082 · Pore-SI Bone Graft Substitute · Apatech, Ltd. · 2004K030131 · Ossatura BCP Bone Void Filler · Isotis NV · 2003K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 1996−50
  1. Root · 5 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 4 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 3 generations backK030131 Ossatura BCP Bone Void FillerIsotis NV · 2003
  4. 2 generations backK040082 Pore-SI Bone Graft SubstituteApatech, Ltd. · 2004
  5. 1 generation backK071206 Actifuse Abx E-Z-Fil Putty Bone Graft SubstituteApatech, Ltd. · 2007 · Recalled
  6. This deviceK130531 UltrafuseBaxter Healthcare Corp · 2014
  7. Descendant · cites it directly · 6 of its ownK181225 AltaporeBaxter Healthcare Corporation · 2018
  8. Descendant · 2 generations on · 4 of its ownK192363 AltaporeBaxter Healthcare Corporation · 2020
  9. Descendant · 2 generations on · 2 of its ownK191513 Altapore ShapeBaxter Healthcare Corporation · 2019
  10. Descendant · 3 generations on · 1 of its ownK201464 Altapore MISBaxter Healthcare Corporation · 2020
  11. Descendant · 3 generations on · 1 of its ownK200640 Altapore ShapeBaxter Healthcare Corporation · 2020

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2018: 12019: 12020: 32024: 2
2018high 3 (2020) · low 0 (2021)2026

Most influential descendants

Showing 5 of 7 · See all
  • K181225AltaporeBaxter Healthcare Corporation · 2018 · cites it directly6descendants
  • K192363AltaporeBaxter Healthcare Corporation · 2020 · 2 generations on4descendants
  • K191513Altapore ShapeBaxter Healthcare Corporation · 2019 · 2 generations on2descendants
  • K201464Altapore MISBaxter Healthcare Corporation · 2020 · 3 generations on1descendant
  • K200640Altapore ShapeBaxter Healthcare Corporation · 2020 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−4K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−3K030131Ossatura BCP Bone Void FillerIsotis NV2003—
−2K040082Pore-SI Bone Graft SubstituteApatech, Ltd.2004—
−1K071206Actifuse Abx E-Z-Fil Putty Bone Graft SubstituteApatech, Ltd.20071
0 (this device)K130531UltrafuseBaxter Healthcare Corp2014—
+1K181225AltaporeBaxter Healthcare Corporation2018—
+2K192363AltaporeBaxter Healthcare Corporation2020—
+2K191513Altapore ShapeBaxter Healthcare Corporation2019—
+3K201464Altapore MISBaxter Healthcare Corporation2020—
+3K200640Altapore ShapeBaxter Healthcare Corporation2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200010
200210
200820

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
201910
202030
202420
FIG. 1 — Lineage of K130531, 1996–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K071206Actifuse Abx E-Z-Fil Putty Bone Graft Substitute
Summary page 1
…Controls per 21 CFR888.3045 Class: Class 11 Product Code: MQV PREDICATE K071206 ABX E-Z-fil Putty Bone Graft Substitute Actifuse®& DEVICES…
Apatech, Ltd.20071
*K081979Actifuse Bone Graft Substitute and E-Z-Fil and Shape Bone Graft Substitute
Summary page 1
…K071206 ABX E-Z-fil Putty Bone Graft Substitute Actifuse®& DEVICES K08 1979 Actifuiseg Bone Graft Substitute Actifuisc® ABX E-Z-fil Putty Bone Graft Su…
Apatech, Ltd.20081
*K082575Actifuse Bone Graft Substitute and Abx E-Z-Fil and Shape Bone Graft Substitutes
Summary page 1
…Actifuise®& Flow Bone Graft Substitute K082575 Actifuiseg Bone Graft Substitute Actifuise® Microgranules Bone Graft Substit…
Apatech, Ltd.20081

Also cleared against K071206: 11 other devices →

What descends from it? (7)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K181225AltaporeBaxter Healthcare Corporation20186

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 5 companies; a new generation was cleared every 2.8 years on median.
  • 3 of the 10 ancestors have a recall of any class.
  • Of its descendants, K181225 (Baxter Healthcare Corporation, 2018) has gone furthest, with 6 descendants of its own.
  • 11 other devices also cite its predicate K071206.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

ALTAPORE is an implant intended to fill bony voids or gaps of the skeletal system i.e., extremities and pelvis. ALTAPORE can be used in combination with autograft as a bone graft extender in the extremities and pelvis. ALTAPORE can be used in combination with autogenous bone marrow aspirate in the extremities and pelvis. These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. ALTAPORE resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K130531: Ultrafuse.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K130531

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026